New England Capital Financial Advisors’s Zimmer Biomet ZBH Stock Holding History

New England Capital Financial Advisors’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$19K	Buy	221 +1	+0.5%	+$88	﹤0.01%	211
2026 Q1	$19.9K	Hold	220	–	–	0.01%	193
2025 Q4	$19.8K	Buy	220 +1	+0.5%	+$95	0.01%	200
2025 Q3	$21.6K	Hold	219	–	–	0.01%	185
2025 Q2	$19.9K	Buy	219 +1	+0.5%	+$97	0.01%	181
2025 Q1	$24.7K	Hold	218	–	–	0.01%	162
2024 Q4	$23K	Buy	218 +1	+0.5%	+$107	0.01%	166
2024 Q3	$23.4K	Hold	217	–	–	0.01%	161
2024 Q2	$23.5K	Buy	217 +1	+0.5%	+$118	0.01%	159
2024 Q1	$28.5K	Hold	216	–	–	0.02%	146
2023 Q4	$26.3K	Buy	216 +1	+0.5%	+$112	0.02%	146
2023 Q3	$24.2K	Hold	215	–	–	0.02%	151
2023 Q2	$31.3K	Hold	215	–	–	0.02%	139
2023 Q1	$27.7K	Buy	215 +1	+0.5%	+$126	0.02%	154
2022 Q4	$26.6K	Buy	+214	New	+$24.8K	0.02%	158

Other funds holding ZBH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

EIC

Equity Investment Corp Atlanta, Georgia $5.24B AUM 11.32% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

New England Capital Financial Advisors's ZBH Position: Q2 2026 in Review

New England Capital Financial Advisors increased its Zimmer Biomet (ZBH) stake by 0.45% in Q2 2026, buying an estimated $88 and bringing the position to 221 shares worth $19K. The position accounts for ﹤0.01% of the portfolio, ranked #211.

New England Capital Financial Advisors first reported a position in ZBH in Q4 2022 and has held it in 15 quarters since. The position peaked at $31.3K in Q2 2023. 616 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

New England Capital Financial Advisors held 221 shares of Zimmer Biomet worth $19K as of Q2 2026.
New England Capital Financial Advisors bought 1 Zimmer Biomet share in Q2 2026, an estimated $88.
Zimmer Biomet made up ﹤0.01% of New England Capital Financial Advisors's portfolio in Q2 2026, its #211 holding.
New England Capital Financial Advisors first reported a position in Zimmer Biomet in Q4 2022 and has held it in 15 quarters since.
New England Capital Financial Advisors's Zimmer Biomet position peaked at $31.3K in Q2 2023.
616 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on New England Capital Financial Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.